Mark Mentser

667 total citations
28 papers, 456 citations indexed

About

Mark Mentser is a scholar working on Pediatrics, Perinatology and Child Health, Transplantation and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark Mentser has authored 28 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pediatrics, Perinatology and Child Health, 9 papers in Transplantation and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark Mentser's work include Renal Transplantation Outcomes and Treatments (9 papers), Pediatric Urology and Nephrology Studies (4 papers) and Neonatal Health and Biochemistry (3 papers). Mark Mentser is often cited by papers focused on Renal Transplantation Outcomes and Treatments (9 papers), Pediatric Urology and Nephrology Studies (4 papers) and Neonatal Health and Biochemistry (3 papers). Mark Mentser collaborates with scholars based in United States, France and Germany. Mark Mentser's co-authors include John D. Mahan, Stephen A. Koff, Chantal Loirat, G. Offner, Martin A. Turman, Patrick Niaudet, Yong W. Cho, Yuichi Iwaki, Brian Hardy and J Cicciarelli and has published in prestigious journals such as Journal of Bone and Joint Surgery, Radiology and The American Journal of Medicine.

In The Last Decade

Mark Mentser

28 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Mentser United States 13 175 166 121 101 72 28 456
Asunción Sancho Spain 15 307 1.8× 165 1.0× 51 0.4× 150 1.5× 114 1.6× 63 566
Sendogan Aker Germany 11 128 0.7× 122 0.7× 41 0.3× 226 2.2× 121 1.7× 17 496
J. Douglas Briggs United Kingdom 11 194 1.1× 203 1.2× 78 0.6× 167 1.7× 106 1.5× 14 654
David van Dellen United Kingdom 11 139 0.8× 248 1.5× 40 0.3× 84 0.8× 106 1.5× 67 537
Keith Rigg United Kingdom 14 262 1.5× 233 1.4× 103 0.9× 79 0.8× 235 3.3× 39 643
R Marcén Spain 12 178 1.0× 139 0.8× 21 0.2× 126 1.2× 95 1.3× 32 399
Glenn H. Bock United States 15 68 0.4× 113 0.7× 103 0.9× 106 1.0× 95 1.3× 32 479
F. Leonetti France 10 82 0.5× 109 0.7× 79 0.7× 366 3.6× 255 3.5× 13 599
L E Ianhez Brazil 13 186 1.1× 215 1.3× 58 0.5× 114 1.1× 194 2.7× 38 559
Markus Hollenbeck Germany 14 116 0.7× 166 1.0× 34 0.3× 143 1.4× 297 4.1× 56 507

Countries citing papers authored by Mark Mentser

Since Specialization
Citations

This map shows the geographic impact of Mark Mentser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Mentser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Mentser more than expected).

Fields of papers citing papers by Mark Mentser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Mentser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Mentser. The network helps show where Mark Mentser may publish in the future.

Co-authorship network of co-authors of Mark Mentser

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Mentser. A scholar is included among the top collaborators of Mark Mentser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Mentser. Mark Mentser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahan, John D., et al.. (2011). Continuous infusion of a standard combination solution in the management of hyperkalemia. Nephrology Dialysis Transplantation. 26(8). 2503–2508. 8 indexed citations
2.
Atkinson, Meredith A., Christopher B. Pierce, Rachel M. Zack, et al.. (2010). Hemoglobin Differences by Race in Children With CKD. American Journal of Kidney Diseases. 55(6). 1009–1017. 18 indexed citations
3.
Ettenger, Robert B., Paul C. Grimm, Nicholas J.A. Webb, et al.. (2008). Multicenter trial of everolimus in pediatric renal transplant recipients: Results at three year. Pediatric Transplantation. 12(4). 456–463. 26 indexed citations
4.
Gradman, Wayne S., et al.. (2005). Experience with Autogenous Arteriovenous Access for Hemodialysis in Children and Adolescents. Annals of Vascular Surgery. 19(5). 609–612. 30 indexed citations
5.
Cho, Yong W., et al.. (2005). Risk Factors for Short- and Long-term Survival of Primary Cadaveric Renal Allografts in Pediatric Recipients: A UNOS Analysis. Transplantation. 80(4). 466–470. 54 indexed citations
6.
Hoyer, Peter F., Robert B. Ettenger, John M. Kovarik, et al.. (2003). Everolimus in pediatric de nova renal transplant patients1. Transplantation. 75(12). 2082–2085. 43 indexed citations
7.
Kovarik, John M., G. Offner, M. Broyer, et al.. (2002). A rational dosing algorithm for basiliximab (Simulect) in pediatric renal transplantation based on pharmacokinetic-dynamic evaluations1. Transplantation. 74(7). 966–971. 42 indexed citations
8.
Offner, G., M. Broyer, Chantal Loirat, et al.. (2000). MULTICENTER STUDY OF THE SAFETY AND TOLERABILITY OF BASILIXIMAB (SIMULECT®) IN DE NOVO PEDIATRIC RENAL TRANSPLANTATION.. Transplantation. 69(Supplement). S258–S259. 5 indexed citations
9.
Tallian, Kimberly, Milap C. Nahata, Martin A. Turman, et al.. (1999). Efficacy of amlodipine in pediatric patients with hypertension. Pediatric Nephrology. 13(4). 304–310. 41 indexed citations
10.
Mentser, Mark, Chantal Loirat, Jennifer Crocker, et al.. (1998). DISPOSITION OF BASILIXIMAB, A CHIMERIC IL-2 RECEPTOR (CD25) MONOCLONAL ANTIBODY, IN PEDIATRIC RENAL TRANSPLANT PATIENTS. Transplantation. 65(12). S66–S66. 3 indexed citations
11.
Kovařík, Josef, Mark Mentser, Chantal Loirat, et al.. (1998). DISPOSITION OF BASILIXIMAB, A CHIMERIC IL-2 RECEPTOR (CD25) MONOCLONAL ANTIBODY, IN PEDIATRIC RENAL TRANSPLANT PATIENTS. Transplantation. 65(Supplement). 142–142. 7 indexed citations
12.
13.
Mahan, John D., Martin A. Turman, & Mark Mentser. (1997). EVALUATION OF HEMATURIA, PROTEINURIA, AND HYPERTENSION IN ADOLESCENTS. Pediatric Clinics of North America. 44(6). 1573–1589. 12 indexed citations
14.
Mahan, John D., Mark Mentser, & Stephen A. Koff. (1996). Doppler flow studies: Applications to pediatric patients. Pediatric Nephrology. 10(1). 121–124. 3 indexed citations
15.
Mentser, Mark, John D. Mahan, & Stephen A. Koff. (1995). Contemporary approaches to renovascular hypertension in children. Pediatric Nephrology. 9(3). 386–388. 1 indexed citations
16.
Mahan, John D., Mark Mentser, & Stephen A. Koff. (1994). Complications of intestinal augmentation and substitution cystoplasty. Pediatric Nephrology. 8(4). 505–507. 6 indexed citations
17.
Mentser, Mark, John D. Mahan, & Stephen A. Koff. (1994). Multicystic dysplastic kidney. Pediatric Nephrology. 8(1). 113–115. 20 indexed citations
18.
Glassman, Andrew H., et al.. (1990). Subtrochanteric pathological fracture of both femora secondary to malignant pheochromocytoma. A case report.. Journal of Bone and Joint Surgery. 72(10). 1554–1558. 1 indexed citations
19.
Miller, Randy R., James A. Menke, & Mark Mentser. (1984). Hypercalcemia associated with phosphate depletion in the neonate. The Journal of Pediatrics. 105(5). 814–817. 12 indexed citations
20.
Mentser, Mark. (1982). Diagnosis and Treatment of Hypertension in Children. Pediatric Clinics of North America. 29(4). 933–945. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Asunción Sancho Breakdown of academic impact, for papers by Sendogan Aker Breakdown of academic impact, for papers by J. Douglas Briggs Breakdown of academic impact, for papers by David van Dellen Breakdown of academic impact, for papers by Keith Rigg Breakdown of academic impact, for papers by R Marcén Breakdown of academic impact, for papers by Glenn H. Bock Breakdown of academic impact, for papers by F. Leonetti Breakdown of academic impact, for papers by L E Ianhez Breakdown of academic impact, for papers by Markus Hollenbeck
Rankless by CCL
2026